The Management of Glucocorticoid-Induced Hyperglycemia in Hospitalized Patients

Completed · Phase 4

Conditions studied: Hyperglycemia, Diabetes Mellitus

In brief

The investigators hypothesize that includes patient weight and glucocorticoid dose can be used to safely initiate insulin treatment in diabetic/hyperglycemic patients who are to be treated with pharmacological doses of glucocorticoids.

Key facts

Study ID

NCT01810952

Run by

Baylor College of Medicine

People needed

37

Starts

2010-09-01

Expected to finish

2013-09-01

Last updated by the study team

2017-02-08

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Admission for Chronic Obstructive Pulmonary Disease (COPD) exacerbation.
• Treatment with pharmacological doses of glucocorticoids (GCs) ≥10 mg of prednisone or its equivalent if they are not on maintenance dose of GCs in the outpatient settings.
• Treatment with pharmacological doses of GCs ≥10 mg of prednisone or its equivalent above their maintenance dose of GCs in the outpatient settings.
• Have either a previous diagnosis of diabetes mellitus which has been treated with diet or medications, hemoglobin A1c ≥6.5%, or confirmed inpatient hyperglycemia defined as a fasting laboratory glucose or finger stick reading ≥126 mg/dL or random glucose reading ≥200 mg/dL on two or more determinations.

You may not qualify if…

• Unwilling to sign informed consent.

Where it is running

• St. Luke's Episcopal Hospital — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.